Loading clinical trials...

Relinking Diagnosed But Untreated HCV Patients Back Into Care. | Clinical Trials | Clareo Health

COMPLETED

Relinking Diagnosed But Untreated HCV Patients Back Into Care.

NCT05975216•Universitair Ziekenhuis Brussel

Summary

Reintroduction of patients into a HCV infection care pathway after a positive chronic hepatitis C diagnosis by previous testing in our hospital who were lost in follow-up. Gaining insight in the possible reasons why patients are lost in follow-up after positive hepatitis C serology.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Positive HCV serology between 2012-2022 with positive or uknown HCV RNA in UZ Brussels database
•≥18 years

Exclusion Criteria

•Positive HCV serology with negative HCV RNA
•Previously eradicated patients in UZ Brussel

Locations (1)

UZ Brussel

Brussels, Belgium

Key Dates

Start Date

July 6, 2023

Primary Completion Date

July 31, 2025

Completion Date

July 31, 2025

Last Updated

August 12, 2025

Enrollment

600

ACTUAL participants

Conditions

Hepatitis C Virus Infection

Interventions

Contact the patient

OTHER

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

NCT05361603

Hepatitis CTransmission, Intravenous Drug Abuser+3 more

View study

NOT_YET_RECRUITING

Screening, Treatment, and Eradication of Hep C

NCT05071261

Hepatitis C Virus Infection

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 12, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Relinking Diagnosed But Untreated HCV Patients Back Into Care.

Inclusion Criteria

Exclusion Criteria

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

Screening, Treatment, and Eradication of Hep C

Pharmacokinetics of Sofosbuvir/Daclatasvir in HCV-infected Lactating Women

HCV Reinfection After DAA Therapy in PWID in Belgium

Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina Faso

HCV Reinfection in HD Patients Achieving SVR